News2020-02-21T20:27:57+00:00

News

1408, 2019

OcellO at AACR-NCI-EORTC Boston: Visit our booth #1628

August 14th, 2019|

OcellO team will be joining AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on the 26-30th October. We look forward to meeting with you ! If you like to set up a one-to-one meeting, you can reach us at [email protected] otherwise come by our booth #1628. Please follow the link for more information about this conference; aacr.org

2603, 2019

Press Release

March 26th, 2019|

OcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics ® programs LEIDEN, the Netherlands, March. 28, 2019 OcellO B.V., a Contract Research Organisation offering 3D cell based assay services for drug discovery to the pharmaceutical industry, today announced that it entered an agreement to provide in vitro research services to Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, for Merus’ MCLA-158 Biclonics® program and [...]

Join to our interesting sessions in the upcoming virtual #EORTC #NCI #AACR Symposium !

#ocellobv #3Dinvitro #immunooncology #oncology #drugdiscovery

OcellO's Picture of the Month is here ! #CRC #organoids co-cultured with #cancer associated #fibroblasts (CAFs) in #3D, greatly captured.

#ocellobv #organoids #CAFs #3Dinvitro

#ADPKD patient kidney tissue cultured #invitro in #3D ! OcellO is leading the way in #3Dinvitro compound testing in ADPKD, which is a devastating disease with no current cure.

#ocellobv #PKD #ADPKD #invitro3D

SAVE THE DATE to join OcellO's ''3D in vitro drug testing for Polycystic Kidney Disease'' webinar on the 2nd of June, Tuesday at 16.30-17.10 CEST (including live Q&A). Interested!? Register here: https://ocellowebinar2020.webinarninja.com/live-webinars/338020/register

Looking forward to seeing you.

#PKD #3Dinvitro #ocellobv

Load More...
Go to Top